Abstract
Ischemic disorders are the main cause of death in the Western world. With more patients surviving their acute myocardial infarction and an aging population, congestive heart failure is the rising health problem. At present, heart transplantation remains the only curative treatment for end stage heart failure. The discrepancy between demand and supply of donor organs does not fill the clinical need. This explains the huge effort made in the field of stem cell research trying to establish alternative resources for tissue replacement. In contrast to adult stem cells mainly acting in a paracrine fashion pluripotent stem cells have the potential to generate transplantable myocardial and vascular tissue.
Due to the low percentage of cardiovascular progenitor cells in pluripotent stem cell cultures, various approaches using exogenous factors aim for their amplification and purification in vitro. However, one future key technology may be genetic forward programming based on profound understanding of differentiation pathways in order to direct stem cell differentiation towards cardiovascular fates. In this regard, subtype specific programming has already been achieved by overexpression of distinct early cardiovascular transcription factors leading to populations of either predominantly early/intermediate type cardiomyocytes or differentiated ventricular myocardial cells, respectively.
In addition, techniques for gentle purification of myocardial and vascular progenitor cells will have to be further refined in order to enable the generation of highly specific, pure and safe cell populations for transplantations and for tissue engineering.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akins RE, Boyce RA, Madonna ML et al (1999) Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. Tissue Eng 5(2):103–118
Balsam LB, Wagers AJ, Christensen JL et al (2004) Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428(6983):668–673
Bel A, Planat-Bernard V, Saito A et al (2010) Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation 122(11 Suppl):S118–S123
Bondue A, Lapouge G, Paulissen C et al (2008) Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell 3(1):69–84
Boyle A, Colvin-Adams M (2004) Recipient selection and management. Semin Thorac Cardiovasc Surg 16(4):358–363
Buckingham M, Meilhac S, Zaffran S (2005) Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 6(11):826–835
David R, Groebner M, Franz WM (2005) Magnetic cell sorting purification of differentiated embryonic stem cells stably expressing truncated human CD4 as surface marker. Stem Cells 23(4):477–482
David R, Brenner C, Stieber J et al (2008a) MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signalling. Nat Cell Biol 10(3):338–345
David R, Theiss H, Franz WM (2008b) Connexin 40 promoter-based enrichment of embryonic stem cell-derived cardiovascular progenitor cells. Cells Tissues Organs 188(1–2):62–69
David R, Stieber J, Fischer E et al (2009) Forward programming of pluripotent stem cells towards distinct cardiovascular cell types. Cardiovasc Res 84(2):263–272
David R, Jarsch V, Schwarz F et al (2011) Induction of MesP1 by Brachyury(T) generates the common multipotent cardiovascular stem cell. Cardiovasc Res 92:115–122
Deindl E, Zaruba MM, Brunner S et al (2006) G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J 20(7):956–958
DESTATIS (2010) Cardiovascular diseases still leading cause of death in 2009. Press release from 18 Oct 2010, German Federal Statistical Office (371)
Eisenberg LM, Eisenberg CA (2006) Wnt signal transduction and the formation of the myocardium. Dev Biol 293(2):305–315
Engelmann MG, Theiss HD, Theiss C et al (2009) G-CSF in patients suffering from late revascularised ST elevation myocardial infarction: final 1-year-results of the G-CSF-STEMI Trial. Int J Cardiol 144:399–404
Gassanov N, Er F, Zagidullin N et al (2004) Endothelin induces differentiation of ANP-EGFP expressing embryonic stem cells towards a pacemaker phenotype. FASEB J 18(14):1710–1712
Gerecht-Nir S, David R, Zaruba M et al (2003) Human embryonic stem cells for cardiovascular repair. Cardiovasc Res 58(2):313–323
Graichen R, Xu X, Braam SR et al (2008) Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 76(4):357–370
Grepin C, Nemer G, Nemer M (1997) Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development 124(12):2387–2395
Hunt SA (1998) Current status of cardiac transplantation. JAMA 280(19):1692–1698
Kanno S, Kim PK, Sallam K et al (2004) Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proc Natl Acad Sci USA 101(33):12277–12281
Kattman SJ, Huber TL, Keller GM (2006) Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 11(5):723–732
Kelly RG, Brown NA, Buckingham ME (2001) The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev Cell 1(3):435–440
Kessler PD, Byrne BJ (1999) Myoblast cell grafting into heart muscle: cellular biology and potential applications. Annu Rev Physiol 61:219–242
Kitajima S, Takagi A, Inoue T et al (2000) MesP1 and MesP2 are essential for the development of cardiac mesoderm. Development 127(15):3215–3226
Kleger A, Seufferlein T, Malan D et al (2010) Modulation of calcium-activated potassium channels induces cardiogenesis of pluripotent stem cells and enrichment of pacemaker-like cells. Circulation 122(18):1823–1836
Klug MG, Soonpaa MH, Koh GY et al (1996) Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 98(1):216–224
Kolossov E, Lu Z, Drobinskaya I et al (2005) Identification and characterization of embryonic stem cell-derived pacemaker and atrial cardiomyocytes. FASEB J 19(6):577–579
Kraehenbuehl TP, Ferreira LS, Hayward AM et al (2011) Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials 32(4):1102–1109
Lam JT, Moretti A, Laugwitz KL (2009) Multipotent progenitor cells in regenerative cardiovascular medicine. Pediatr Cardiol 30(5):690–698
Larsen W (1998) Essentials of human embryology. Library of congress cataloging-in-publication data, 2nd edn. Churchill Livingstone, New York
Laugwitz KL, Moretti A, Caron L et al (2008) Islet1 cardiovascular progenitors: a single source for heart lineages? Development 135(2):193–205
Leal J, Luengo-Fernandez R, Gray A et al (2006) Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 27(13):1610–1619
Lee MS, Makkar RR (2004) Stem-cell transplantation in myocardial infarction: a status report. Ann Intern Med 140(9):729–737
Liao SY, Liu Y, Siu CW et al (2010) Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium. Heart Rhythm 7(12):1852–1859
Lin Q, Fu Q, Zhang Y et al (2010) Tumourigenesis in the infarcted rat heart is eliminated through differentiation and enrichment of the transplanted embryonic stem cells. Eur J Heart Fail 12(11):1179–1185
Lindsley RC, Gill JG, Murphy TL et al (2008) Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs. Cell Stem Cell 3(1):55–68
Liu HS, Jan MS, Chou CK et al (1999) Is green fluorescent protein toxic to the living cells? Biochem Biophys Res Commun 260(3):712–717
Lyons I, Parsons LM, Hartley L et al (1995) Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 9(13):1654–1666
Maltsev VA, Rohwedel J, Hescheler J et al (1993) Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev 44(1):41–50
Meilhac SM, Esner M, Kelly RG et al (2004) The clonal origin of myocardial cells in different regions of the embryonic mouse heart. Dev Cell 6(5):685–698
Menasche P (2005) Skeletal myoblast for cell therapy. Coron Artery Dis 16(2):105–110
Menasche P, Hagege AA, Vilquin JT et al (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41(7):1078–1083
Müller M, Fleischmann BK, Selbert S et al (2000) Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J 14(15):2540–2548
Mummery CL, Ward D and Passier R (2007) Differentiation of human embryonic stem cells to cardiomyocytes by coculture with endoderm in serum-free medium. Curr Protoc Stem Cell Biol Chapter 1: Unit 1F 2
Murry CE, Soonpaa MH, Reinecke H et al (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428(6983):664–668
Nelson TJ, Faustino RS, Chiriac A et al (2008) CXCR4+/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells. Stem Cells 26(6):1464–1473
Neumayer HH (2005) Introducing everolimus (Certican) in organ transplantation: an overview of preclinical and early clinical developments. Transplantation 79(9 Suppl):S72–S75
Okano T, Yamada N, Okuhara M et al (1995) Mechanism of cell detachment from temperature-modulated, hydrophilic-hydrophobic polymer surfaces. Biomaterials 16(4):297–303
Orlic D, Kajstura J, Chimenti S et al (2001) Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 938:221–229; discussion 229–230
Paquin J, Danalache BA, Jankowski M et al (2002) Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci USA 99(14):9550–9555
Potta SP, Liang H, Winkler J et al (2010) Isolation and functional characterization of alpha-smooth muscle actin expressing cardiomyocytes from embryonic stem cells. Cell Physiol Biochem 25(6):595–604
Roggia C, Ukena C, Bohm M et al (2006) Hepatocyte growth factor (HGF) enhances cardiac commitment of differentiating embryonic stem cells by activating PI3 kinase. Exp Cell Res 313:921–930
Sadler T (1998) Medizinische Embryologie – Die normale menschliche Entwicklung und ihre Fehlbildungen 11th edition, Thieme, Stuttgart, Germany, ISBN-10: 3134466112, ISBN-13 978-3134466119 (german)
Saga Y, Miyagawa-Tomita S, Takagi A et al (1999) MesP1 is expressed in the heart precursor cells and required for the formation of a single heart tube. Development 126(15):3437–3447
Saga Y, Kitajima S, Miyagawa-Tomita S (2000) Mesp1 expression is the earliest sign of cardiovascular development. Trends Cardiovasc Med 10(8):345–352
Schachinger V, Erbs S, Elsasser A et al (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355(12):1210–1221
Shiba Y, Hauch KD, Laflamme MA (2009) Cardiac applications for human pluripotent stem cells. Curr Pharm Des 15(24):2791–2806
Singh AM, Li FQ, Hamazaki T, et al. (2007). Chibby, an Antagonist of the Wnt/{beta}-Catenin Pathway, Facilitates Cardiomyocyte Differentiation of Murine Embryonic Stem Cells. Circulation 115:617–626
Singla DK, Long X, Glass C et al (2011) iPS cells repair and regenerate infarcted myocardium. Mol Pharm 8:1573–1581
Soonpaa MH, Koh GY, Klug MG et al (1994) Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 264(5155):98–101
Srivastava D, Ivey KN (2006) Potential of stem-cell-based therapies for heart disease. Nature 441(7097):1097–1099
Strauer BE, Brehm M, Zeus T et al (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106(15):1913–1918
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676
Takahashi T, Lord B, Schulze PC et al (2003) Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 107(14):1912–1916
Theiss HD, Brenner C, Engelmann MG et al (2010) Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from acute myocardial infarction (SITAGRAMI-trial) – rationale, design and first interim analysis. Int J Cardiol 145(2):282–284
Tulloch NL, Muskheli V, Razumova MV et al (2011) Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 109(1):47–59
Ventura C, Maioli M, Asara Y et al (2004) Butyric and retinoic mixed ester of hyaluronan. A novel differentiating glycoconjugate affording a high throughput of cardiogenesis in embryonic stem cells. J Biol Chem 279(22):23574–23579
Ventura C, Maioli M, Asara Y et al (2005) Turning on stem cell cardiogenesis with extremely low frequency magnetic fields. FASEB J 19(1):155–157
Wiese C, Nikolova T, Zahanich I et al (2011) Differentiation induction of mouse embryonic stem cells into sinus node-like cells by suramin. Int J Cardiol 147(1):95–111
Wobus AM, Kaomei G, Shan J et al (1997) Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol 29(6):1525–1539
Wollert KC, Meyer GP, Lotz J et al (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364(9429):141–148
Wu SM (2008) Mesp1 at the heart of mesoderm lineage specification. Cell Stem Cell 3(1):1–2
Xu XQ, Graichen R, Soo SY et al (2008) Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation 76(9):958–970
Yamanaka S (2007) Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1(1):39–49
Yuasa S, Itabashi Y, Koshimizu U et al (2005) Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat Biotechnol 23(5):607–611
Zaffran S, Kelly RG, Meilhac SM et al (2004) Right ventricular myocardium derives from the anterior heart field. Circ Res 95(3):261–268
Zandstra PW, Bauwens C, Yin T et al (2003) Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng 9(4):767–778
Zaruba MM, Theiss HD, Vallaster M et al (2009) Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 4(4):313–323
Zimmermann WH, Cesnjevar R (2009) Cardiac tissue engineering: implications for pediatric heart surgery. Pediatr Cardiol 30(5):716–723
Zweigerdt R, Burg M, Willbold E et al (2003) Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategies. Cytotherapy 5(5):399–413
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Brenner, C., David, R., Franz, WM. (2013). Cardiovascular Stem Cells. In: Steinhoff, G. (eds) Regenerative Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5690-8_11
Download citation
DOI: https://doi.org/10.1007/978-94-007-5690-8_11
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5689-2
Online ISBN: 978-94-007-5690-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)